ArticleCureus2025
Utilization of Gallium-68 Fibroblast Activation Protein Inhibitor Positron Emission Tomography (⁶⁸Ga-FAPI PET) for Head and Neck Malignancies With Neck Imaging Reporting and Data System (Ni-RADS) Correlation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Value ofMolecular imaging and radionuclide therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Head and neck cancers (HNCs) encompass a group of malignancies that arise in the mucosal surfaces of the oral cavity, pharynx, larynx, and other related structures. Advances in imaging modalities such as positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) have improved tumor detection and staging, aiding in personalized treatment approaches. PET-CT is used to diagnose and stage various cancers. Interpretation of neck masses can be quite challenging, particularly in the context of prior surgery and radiotherapy. A standardized lexicon and risk classification system for interpreting images in patients treated for HNC has been developed by the American College of Radiology (ACR) Neck Imaging Reporting and Data System (Ni-RADS) Committee. While fluorine-18 fluorodeoxyglucose (18F-FDG) PET-CT is widely used to assess head and neck malignancies, we have chosen to employ gallium-68 fibroblast activation protein inhibitor (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.